Women's Health Diagnostics Market 2022-2028

Description

List of Tables

Global Women's Health Diagnostics Market Size, Share & Trends Analysis Report by Diagnostic Devices(Biopsy Devices, and Tests) by Application (Breast Cancer Testing, PAP Smear (PAP) and HPV Test, Infectious Disease Testing, Osteoporosis Testing, Pregnancy, and Fertility Testing, Sexually Transmitted Disease Testing, and Others) and by End User (Home Care, Hospitals & Clinics, and Diagnostic and Imaging Centers) Forecast Period (2022-2028)

The global women's health diagnostics market is anticipated to grow at a substantial CAGR of 7.5% during the forecast period. An increasing investments initiatives by key players are accepted to contribute to the growth of the market. Moreover, such initiatives are greater in the availability of more comfortable and convenient option that leads to great adoption of medical devices. For instance, in March 2022, Willow launched a new cord-free smart breast pump. It is priced at $329 and will be available with insurance plans that offer breast pumps for free or at a reduced cost, many will only cover the cost of a manual breast pump.

The global women's health diagnostics market is segmented based on diagnostic devices, application, and end-user. Based on diagnostic devices, the market is segmented into biopsy devices and tests. Based on the application, the market is sub-classified into cancer testing, PAP smear (PAP) and HPV test, infectious disease testing, osteoporosis testing, pregnancy, and fertility testing, sexually transmitted disease testing, and others. Based on the end-user, the market is sub-divided into home care, hospitals & clinics, and diagnostic and imaging centers. Among the end-user segment, the hospitals & clinics segment is dominating owing to the high number of patients visits and rising diagnostic procedures related to women health.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is likely to dominate the market during the forecast period. The regional growth is attributed to the presence of better healthcare infrastructure, and increased women's major health issues which is positively influencing the region's markets growth. Moreover, regulatory approval from the government authority is also propelling the growth of the market in North America. For instance, in January 2021, the Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has approved Seno Medical Instruments Inc., for its Imagio Breast Imaging System. This system is groundbreaking diagnostic breast cancer imaging technology, and it will help physicians better differentiate between benign and malignant breast lesions.

The major companies serving the global women's health diagnostics market include F. Hoffmann-La Roche Lt, General Electric Co., Hologic Inc., Myriad Genetics, Inc., MedGyn Products Inc., and PerkinElmer Inc., Siemens Medical Solutions USA, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Abbott has acquired Walk Vascular, to expand its peripheral vascular offerings. The peripheral thrombectomy systems of Walk Vascular will be integrated into the endovascular products portfolio. Moreover, Walk Vascular JETi Peripheral Thrombectomy System and JETi AIO (All In One) Peripheral Thrombectomy System are systems that are used to remove intravascular clots known as thrombus.

Research Methodology

The market study of the global women's health diagnostics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

Financial reports of companies involved in the market.
Whitepapers, research papers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Women's Health Diagnostics Market Research and Analysis by Device

2. Global Women's Health Diagnostics Market Research and Analysis by Test

3. Global Women's Health Diagnostics Market Research and Analysis by End-User

The Report Covers:

Comprehensive Research Methodology of the global women's health diagnostics market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global women's health diagnostics market.
Insights about market determinants that are stimulating the global women's health diagnostics market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2026422

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the Global Women's Health Diagnostics Market
Recovery Scenario of Global Women's Health Diagnostics Market
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. BY Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. F. Hoffmann-La Roche Ltd
- 3.1.1. Overview
- 3.1.2. Financial Analysis
- 3.1.3. SWOT Analysis
- 3.1.4. Recent Developments
3.2. General Electric Co.
- 3.2.1. Overview
- 3.2.2. Financial Analysis
- 3.2.3. SWOT Analysis
- 3.2.4. Recent Developments
3.3. Hologic, Inc.
- 3.3.1. Overview
- 3.3.2. Financial Analysis
- 3.3.3. SWOT Analysis
- 3.3.4. Recent Developments
3.4. PerkinElmer Inc.
- 3.4.1. Overview
- 3.4.2. Financial Analysis
- 3.4.3. SWOT Analysis
- 3.4.4. Recent Developments
3.5. Siemens Medical Solutions USA, Inc.
- 3.5.1. Overview
- 3.5.2. Financial Analysis
- 3.5.3. SWOT Analysis
- 3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

4.1. Global Women's Health Diagnostics Market by Type
- 4.1.1. Diagnostic Devices
- 4.1.2. Diagnostic Tests
4.2. Global Women's Health Diagnostics Market by Application
- 4.2.1. Breast Cancer Testing
- 4.2.2. PAP Smear (PAP) and HPV Test
- 4.2.3. Infectious Disease Testing
- 4.2.4. Osteoporosis Testing
- 4.2.5. Pregnancy and Fertility Testing
- 4.2.6. Sexually Transmitted Disease Testing
- 4.2.7. Other
4.3. Global Women's Health Diagnostics Market by End-User
- 4.3.1. Home Care
- 4.3.2. Hospitals & Clinics
- 4.3.3. Diagnostic and Imaging Centers

5. Regional Analysis

5.1. North America
- 5.1.1. US
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. Abbott Laboratories
6.2. Becton, Dickinson and Co
6.3. BIOMERIEUX, INC.
6.4. Bio-Rad Laboratories, Inc.
6.5. BOSTON IMAGING
6.6. Canon Medical Systems Corp.
6.7. Carestream Health, Inc.
6.8. Cook Group Inc
6.9. DiaSorin S.p.A
6.10. Grifols, S.A.
6.11. Konica Minolta Healthcare Americas, Inc.
6.12. Laboratory Corp.
6.13. Myriad Genetics, Inc.
6.14. MedGyn Products, Inc.
6.15. Ortho Clinical Diagnostics
6.16. Philips International B.V.,
6.17. Quest Diagnostics
6.18. Thermo Fisher Scientific Inc.
6.19. Ziehm Imaging GmbH